InsiderTrades.com logo

YARW Insider Trading

Insider Ownership Percentage: 3.03%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Yarrow Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at Yarrow Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Yarrow Bioscience Share Price & Price History

Current Price: $30.93
Price Change: ▲ Price Increase of +2.08 (7.21%)
As of 09/4/2026 02:03 PM ET

This chart shows the closing price history over time for YARW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Yarrow Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/15/2025Patrick G LePoreDirectorBuy300$146.00$43,800.001,029View SEC Filing Icon  
11/15/2023Patrick G LePoreDirectorBuy260$195.50$50,830.00729View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Yarrow Bioscience (NASDAQ:YARW)

83.78% of Yarrow Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YARW by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Yarrow Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2026Braidwell LP916,077$0.60M0.0%N/A136.728%Search for SEC Filing on Google Icon
8/20/2026Susquehanna International Group LLP118,957$77K0.0%N/A17.755%Search for SEC Filing on Google Icon
8/20/2026Two Sigma Securities LLC40,697$26K0.0%N/A6.074%Search for SEC Filing on Google Icon
8/19/2026Nantahala Capital Management LLC2,000,000$1.30B0.0%N/A298.507%Search for SEC Filing on Google Icon
8/14/2026ADAR1 Capital Management LLC2,950,000$1.92M0.1%N/A440.299%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.44,405$29K0.0%N/A6.628%Search for SEC Filing on Google Icon
8/6/2026GSA Capital Partners LLP71,533$47K0.0%N/A10.677%Search for SEC Filing on Google Icon
5/19/2026Anson Funds Management LP1,243,106$0.74M0.1%-2.5%3.731%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC1,063,899$0.64M0.0%+319.2%3.193%Search for SEC Filing on Google Icon
5/15/2026Rangeley Capital LLC118,064$71K0.1%+18.1%0.354%Search for SEC Filing on Google Icon
2/18/2026KVP Capital Advisors LP500,551$0.29M0.3%N/A1.504%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd79,040$46K0.0%N/A0.237%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC264,912$0.15M0.0%-8.7%0.796%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC81,371$47K0.0%-23.6%0.244%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC253,791$0.15M0.0%N/A0.762%Search for SEC Filing on Google Icon
2/17/2026Anson Funds Management LP1,274,386$0.74M0.1%N/A3.828%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC1,000,000$0.58M0.0%N/A3.004%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC72,356$42K0.0%-50.8%0.217%Search for SEC Filing on Google Icon
2/11/2026T3 Companies LLC945,000$0.55M0.7%N/A2.839%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC225,152$0.13M0.0%+64.2%0.676%Search for SEC Filing on Google Icon
11/17/2025Acorn Capital Advisors LLC586,572$0.20M0.1%-20.4%1.762%Search for SEC Filing on Google Icon
11/17/2025Baker BROS. Advisors LP851,353$0.29M0.0%N/A2.557%Search for SEC Filing on Google Icon
11/14/2025Shay Capital LLC492,577$0.17M0.0%N/A1.934%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP220,788$74K0.0%N/A0.867%Search for SEC Filing on Google Icon
8/15/2025Exome Asset Management LLC208,970$0.35M0.2%-54.8%1.374%Search for SEC Filing on Google Icon
8/15/2025Boothbay Fund Management LLC106,459$0.18M0.0%N/A0.700%Search for SEC Filing on Google Icon
8/15/2025Acorn Capital Advisors LLC736,572$1.22M0.8%-6.3%4.843%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.644,134$1.06M0.0%+87.2%4.235%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC124,822$0.21M0.0%N/A0.821%Search for SEC Filing on Google Icon
8/14/2025TFG Asset Management GP Ltd115,384$0.19M0.0%N/A0.759%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP30,000$50K0.0%N/A0.197%Search for SEC Filing on Google Icon
8/13/2025Kennedy Capital Management LLC570,740$0.94M0.0%N/A3.752%Search for SEC Filing on Google Icon
8/11/2025Patient Square Capital LP317,033$0.52M0.2%+23.3%2.084%Search for SEC Filing on Google Icon
5/19/2025Acorn Capital Advisors LLC785,938$1.24M0.8%+72.0%5.167%Search for SEC Filing on Google Icon
5/16/2025Exome Asset Management LLC462,801$0.73M0.6%+30.9%3.043%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC217,978$0.34M0.0%+42.5%1.433%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.344,134$0.54M0.0%+123.3%2.263%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC70,419$0.11M0.0%N/A0.463%Search for SEC Filing on Google Icon
5/15/2025DAFNA Capital Management LLC636,103$1.01M0.3%N/A4.182%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC19,574$31K0.0%N/A0.129%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd33,052$52K0.0%+57.3%0.217%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC152,973$0.51M0.1%-24.6%1.037%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC245,800$0.82M0.1%N/A1.666%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC36,958$0.12M0.0%N/A0.251%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC456,970$1.53M0.8%N/A3.098%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC20,286$68K0.0%N/A0.138%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC176,658$0.59M0.0%+4.8%1.198%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp23,971$80K0.0%-35.7%0.163%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.154,134$0.52M0.0%N/A1.045%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd21,018$70K0.0%N/A0.142%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC24,943$84K0.0%-71.2%0.169%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC202,973$0.38M0.0%-41.2%1.376%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC268,485$0.51M0.4%-13.5%1.820%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP16,194$32K0.0%N/A0.111%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC63,111$0.12M0.0%-21.7%0.434%Search for SEC Filing on Google Icon
7/26/2024AlphaCentric Advisors LLC310,500$0.61M0.5%-30.2%2.137%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC16,199$50K0.0%N/A0.112%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC1,394,336$3.25M0.1%N/A9.988%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC696,470$1.62M0.2%N/A4.990%Search for SEC Filing on Google Icon
5/15/2023DSC Advisors L.P.115,000$0.35M0.3%-92.7%3.523%Search for SEC Filing on Google Icon
5/10/2023Staley Capital Advisers Inc.23,472$72K0.0%-62.4%0.720%Search for SEC Filing on Google Icon
10/7/2022Mackenzie Financial Corp134,920$30K0.0%+106.8%0.233%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Yarrow Bioscience logo
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
Read More on Yarrow Bioscience

Today's Range

Now: $30.93
Low: $29.04
High: $31.90

50 Day Range

MA: N/A

52 Week Range

Now: $30.93
Low: $14.02
High: $46.95

Volume

19,502 shs

Average Volume

14,216 shs

Market Capitalization

$82.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01

Who are the company insiders with the largest holdings of Yarrow Bioscience?

Yarrow Bioscience's top insider investors include:
  1. David Domzalski (CEO)
  2. Patrick G Lepore (Director)
  3. Mutya Harsch (Insider)
  4. Andrew Saik (CFO)
  5. Perceptive Advisors Llc (Major Shareholder)
  6. Presidio Partners 2007 Gp, LP (Insider)
  7. Vivo Capital Surplus Fund Viii (Major Shareholder)
Learn More about top insider investors at Yarrow Bioscience.

Who are the major institutional investors of Yarrow Bioscience?

Yarrow Bioscience's top institutional shareholders include:
  1. ADAR1 Capital Management LLC — 440.30%
  2. Nantahala Capital Management LLC — 298.51%
  3. Braidwell LP — 136.73%
  4. Susquehanna International Group LLP — 17.75%
  5. GSA Capital Partners LLP — 10.68%
  6. BlackRock Inc. — 6.63%
Learn More about top institutional investors of Yarrow Bioscience stock.

Which major investors are buying Yarrow Bioscience stock?

In the previous quarter, YARW stock was bought by institutional investors including:
  1. ADAR1 Capital Management LLC
  2. Nantahala Capital Management LLC
  3. Braidwell LP
  4. Susquehanna International Group LLP
  5. GSA Capital Partners LLP
  6. BlackRock Inc.
  7. Two Sigma Securities LLC

Yarrow Bioscience Active Insiders

Patrick G Lepore
Patrick G Lepore
Director